Sclerotherapy for Spider Veins
Spider Veins
Spider
veins, known to doctors as telangietasias,
are those small yet unsightly clusters of red,
blue or purple veins that most commonly appear
on the thighs, calves and ankles. They are small
thin veins that lie close to the superficial
surface of the skin. They are connected to the
larger veins, but are not an essential part of
the venous system.

Causes of Spider Veins:
-
Hereditary
-
Pregnancy
-
Prolonged standing or sitting
It is
estimated that at least half of the adult female
population is plagued with this common cosmetic
problem. The age of onset can vary from teenage
to forties.
Spider veins
can develop on the face too. These may be
amenable to mesotherapy or IPL.
Sclerotherapy
Sclerotherapy is a treatment that shrinks
superficial leg veins such as spider veins. The
veins disappear from view.
Even the physical effects often associated
with spider veins can disappear. These include:
- Aching
- Burning
- Swelling
- Night Cramps
This technique has been popular in Europe for
the past 50 years, and has increased in
popularity in the USA for the last decade.
Spider veins and other superficial veins are
dilated veins that appear pink, red, purple, or
blue in color. The color difference is due to
differences in size and depth.
Sclerotherapy involves the injection of
irritant solutions into the dilated vein, which
causes them to scar and close off. The veins
will look more faint after each treatment.
Patients average 2-6 treatments in 4-6 week
intervals.

The treatment shrinks the superficial veins
that are visible and does nothing to prevent new
veins from forming from the deeper vessels.
After the procedure, special compression
stockings will have to be worn. There will be
some bruising and discoloration which can last a
few weeks.
Those with a history of phlebitis in the
legs, diabetes, vascular problems, or ulcers in
the leg cannot receive Sclerotherapy treatment.
An initial consultation is required. The number
of treatments varies with the type of vein and
the number of treatments will be discussed
further after a detailed consultation
evaluation.
 |